Autres langues HANDOK Inc.

Actions

A002390

KR7002390003

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 10/06/2024			Varia. 5j.	Varia. 1 janv.
15 250 ^KRW	-1,61 %		-2,12 %	+6,64 %

24/05	Biocon s'associe à Handok pour commercialiser l'antidiabétique Liraglutide en Corée du Sud	MT
24/05	Biocon Limited signe un accord exclusif de licence et d'approvisionnement pour la commercialisation du Liraglutide en Corée du Sud avec Handok Inc.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Biocon Ties Up with Handok to Market Anti-Diabetic Drug Liraglutide in South Korea	24/05
Biocon Limited Signs Exclusive Licensing and Supply Deal for the Commercialization of Liraglutide in South Korea with Handok Inc	24/05
Nxera Pharma Partners with Handok c. to Distribute PIVLAZ in South Korea,	16/04
Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for Pivlaz in South Korea	15/04
Sobi and Handok establish joint venture for rare disease business in South Korea	14/02
Sobi to Expand in South Korea via Rare Disease JV with Handok	13/02
HANDOK Inc.(KOSE:A002390) dropped from S&P Global BMI Index	18/09/23
Hogere omzet en kleiner verlies voor Argenx	27/07/23
HANDOK Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Rezolute Unveils Plans for Secondary Offering of 3.24 Million Shares	28/10/22
I-Mab Completes Enrollment in China Phase 3 Trial of Eftansomatropin Alfa in Pediatric Growth Hormone Deficiency	14/06/22
AUM Biosciences Enters in A Strategic Collaboration with Handok and CMG Pharm to Develop ‘CHC2014’, New Pan-TRK Inhibitor for Cancer Treatment	11/05/21
WELT Corp., Ltd announced that it has received KRW 6 billion in funding from HANDOK Inc., Smilegate Investment, Inc., POSCO Venture Capital Co., Ltd.	25/03/21
Adicet Bio, Inc. announced that it has received $80 million in funding from a group of investors	02/10/19
Rezolute, Inc. announced that it has received $24.05 million in funding from Genexine, Inc., Handok, Inc., District 2 Capital Fund LP, The Bigger Capital Fund, LP and another investor	12/08/19
Adicet Bio, Inc. announced that it expects to receive $80 million in funding	25/07/19
Rezolute, Inc. announced that it expects to receive $20.25 million in funding from District 2 Capital Fund LP, The Bigger Capital Fund, LP, Genexine, Inc., Handok, Inc.	23/07/19
TRIGR Therapeutics, Inc announced that it has received $14 million in funding from Handok Inc.	25/03/19
BiomX Ltd announced that it has received $32 million in funding from a group of investors	20/02/19
Rezolute, Inc. announced that it has received $25 million in funding from Genexine, Inc., Handok, Inc.	30/01/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues HANDOK Inc.

Actions

A002390

KR7002390003

Autres langues

Filtres